Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 5
1966 5
1967 2
1968 1
1969 1
1970 1
1971 1
1972 2
1974 6
1975 2
1976 2
1977 1
1978 7
1979 8
1980 4
1981 6
1982 8
1983 10
1984 13
1985 8
1986 6
1987 5
1988 22
1989 55
1990 35
1991 39
1992 30
1993 16
1994 25
1995 31
1996 17
1997 26
1998 33
1999 53
2000 43
2001 37
2002 46
2003 65
2004 62
2005 48
2006 56
2007 50
2008 37
2009 49
2010 48
2011 50
2012 91
2013 92
2014 87
2015 79
2016 59
2017 81
2018 99
2019 82
2020 96
2021 117
2022 93
2023 42

Text availability

Article attribute

Article type

Publication date

Search Results

1,895 results

Results by year

Filters applied: . Clear all
Page 1
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
Yaku A, Inagaki T, Asano R, Okazawa M, Mori H, Sato A, Hia F, Masaki T, Manabe Y, Ishibashi T, Vandenbon A, Nakatsuka Y, Akaki K, Yoshinaga M, Uehata T, Mino T, Morita S, Ishibashi-Ueda H, Morinobu A, Tsujimura T, Ogo T, Nakaoka Y, Takeuchi O. Yaku A, et al. Among authors: masaki t. Circulation. 2022 Sep 27;146(13):1006-1022. doi: 10.1161/CIRCULATIONAHA.122.059435. Epub 2022 Aug 23. Circulation. 2022. PMID: 35997026
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension.
Masaki T, Okazawa M, Asano R, Inagaki T, Ishibashi T, Yamagishi A, Umeki-Mizushima S, Nishimura M, Manabe Y, Ishibashi-Ueda H, Shirai M, Tsuchimochi H, Pearson JT, Kumanogoh A, Sakata Y, Ogo T, Kishimoto T, Nakaoka Y. Masaki T, et al. Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2023899118. doi: 10.1073/pnas.2023899118. Proc Natl Acad Sci U S A. 2021. PMID: 33836606 Free PMC article.
Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis.
Zwager LW, Bastiaansen BAJ, Montazeri NSM, Hompes R, Barresi V, Ichimasa K, Kawachi H, Machado I, Masaki T, Sheng W, Tanaka S, Togashi K, Yasue C, Fockens P, Moons LMG, Dekker E. Zwager LW, et al. Among authors: masaki t. Gastroenterology. 2022 Jul;163(1):174-189. doi: 10.1053/j.gastro.2022.04.010. Epub 2022 Apr 15. Gastroenterology. 2022. PMID: 35436498 Free article.
MicroRNA as a Biomarker in Gastroenterological Cancers.
Morishita A, Shirakami Y, Okumura T, Masaki T. Morishita A, et al. Among authors: masaki t. Int J Mol Sci. 2022 Apr 24;23(9):4701. doi: 10.3390/ijms23094701. Int J Mol Sci. 2022. PMID: 35563092 Free PMC article.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: masaki t. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
1,895 results